4th Inflammasome Therapeutics Summit
29th November to 1st December 2022
Boston, Massachusetts, United States of America
Contact person: Jessica Durston
Decipher Dysregulated Inflammasome Signaling, Identify Clinically Meaningful Biomarkers of Inflammasome Inhibition and Recharge Inflammasome-Targeted Drug Development Within NLRP3 and Beyond. Time: 09:00 - 16:30. Prices: USD 2199.00 - USD 5696.00.
Organized by: Hanson Wade
Check the event website for more details.
View all events from this organizer.
Events with same date and place 3rd CRISPR 2.0 Summit 2022
6th Obesity and NASH Drug Development Summit 2022